Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 83 entries
Sorted by: Best Match Show Resources per page
Editorial: Is decision analysis useful in clinical medicine?.

The Yale journal of biology and medicine

Ransohoff DF, Feinstein AR.
PMID: 941464
Yale J Biol Med. 1976 May;49(2):165-8.
Free PMC Article

No abstract available.

Cite
Ransohoff DF, Feinstein AR. Editorial: Is decision analysis useful in clinical medicine?. Yale J Biol Med. 1976;49(2):165-8
Ransohoff, D. F., & Feinstein, A. R. (1976). Editorial: Is decision analysis useful in clinical medicine?. The Yale journal of biology and medicine, 49(2), 165-8.
Ransohoff, D F, and Feinstein, A R. "Editorial: Is decision analysis useful in clinical medicine?." The Yale journal of biology and medicine vol. 49,2 (1976): 165-8.
Ransohoff DF, Feinstein AR. Editorial: Is decision analysis useful in clinical medicine?. Yale J Biol Med. 1976 May;49(2):165-8. PMID: 941464; PMCID: PMC2595280.
Copy Download .nbib Format: NLM
Spatiotemporal ablation of CXCR2 on oligodendrocyte lineage cells: Role in myelin repair.

Neurology(R) neuroimmunology & neuroinflammation

Liu L, Spangler LC, Prager B, Benson B, Hu B, Shi S, Love A, Zhang C, Yu M, Cotleur AC, Ransohoff RM.
PMID: 26668819
Neurol Neuroimmunol Neuroinflamm. 2015 Nov 19;2(6):e174. doi: 10.1212/NXI.0000000000000174. eCollection 2015 Dec.

BACKGROUND: Residual CXCR2 expression on CNS cells in Cxcr2 (+/-) →Cxcr2 (-/-) chimeric animals slowed remyelination after both experimental autoimmune encephalomyelitis and cuprizone-induced demyelination.METHODS: We generated Cxcr2 (fl/-) :PLPCre-ER(T) mice enabling an inducible, conditional deletion of Cxcr2 on oligodendrocyte...

Cite
Liu L, Spangler LC, Prager B, et al. Spatiotemporal ablation of CXCR2 on oligodendrocyte lineage cells: Role in myelin repair. Neurol Neuroimmunol Neuroinflamm. 2015;2(6):e174doi: 10.1212/NXI.0000000000000174.
Liu, L., Spangler, L. C., Prager, B., Benson, B., Hu, B., Shi, S., Love, A., Zhang, C., Yu, M., Cotleur, A. C., & Ransohoff, R. M. (2015). Spatiotemporal ablation of CXCR2 on oligodendrocyte lineage cells: Role in myelin repair. Neurology(R) neuroimmunology & neuroinflammation, 2(6), e174. https://doi.org/10.1212/NXI.0000000000000174
Liu, LiPing, et al. "Spatiotemporal ablation of CXCR2 on oligodendrocyte lineage cells: Role in myelin repair." Neurology(R) neuroimmunology & neuroinflammation vol. 2,6 (2015): e174. doi: https://doi.org/10.1212/NXI.0000000000000174
Liu L, Spangler LC, Prager B, Benson B, Hu B, Shi S, Love A, Zhang C, Yu M, Cotleur AC, Ransohoff RM. Spatiotemporal ablation of CXCR2 on oligodendrocyte lineage cells: Role in myelin repair. Neurol Neuroimmunol Neuroinflamm. 2015 Nov 19;2(6):e174. doi: 10.1212/NXI.0000000000000174. eCollection 2015 Dec. PMID: 26668819; PMCID: PMC4676354.
Copy Download .nbib Format: NLM
Surgical Treatment of Metastatic Brain Tumors.

Cancer control : journal of the Moffitt Cancer Center

Ransohoff J, Smith D.
PMID: 10862171
Cancer Control. 1995 Jul;2(4):315-319.

Metastasis to the brain is a major cause of mortality and morbidity in patients with cancer. Lung, breast, and renal cancers as well as melanomas are particularly prone to producing this complication. Brain metastases may be clinically silent or...

Cite
Ransohoff J, Smith D. Surgical Treatment of Metastatic Brain Tumors. Cancer Control. 1995;2(4):315-319
Ransohoff, J., & Smith, D. (1995). Surgical Treatment of Metastatic Brain Tumors. Cancer control : journal of the Moffitt Cancer Center, 2(4), 315-319.
Ransohoff, and Smith. "Surgical Treatment of Metastatic Brain Tumors." Cancer control : journal of the Moffitt Cancer Center vol. 2,4 (1995): 315-319.
Ransohoff J, Smith D. Surgical Treatment of Metastatic Brain Tumors. Cancer Control. 1995 Jul;2(4):315-319. PMID: 10862171.
Copy Download .nbib Format: NLM
The treatment of anterior poliomyelitis.

The Medical clinics of North America

RANSOHOFF NS.
PMID: 15410172
Med Clin North Am. 1950 Mar;34(2):553-62.

No abstract available.

Cite
RANSOHOFF NS. The treatment of anterior poliomyelitis. Med Clin North Am. 1950;34(2):553-62
RANSOHOFF, N. S. (1950). The treatment of anterior poliomyelitis. The Medical clinics of North America, 34(2), 553-62.
RANSOHOFF, N S. "The treatment of anterior poliomyelitis." The Medical clinics of North America vol. 34,2 (1950): 553-62.
RANSOHOFF NS. The treatment of anterior poliomyelitis. Med Clin North Am. 1950 Mar;34(2):553-62. PMID: 15410172.
Copy Download .nbib Format: NLM
SOLID TUMORS OF THE MESENTERY.

Annals of surgery

Ransohoff JL, Friedlander A.
PMID: 17864414
Ann Surg. 1921 Feb;73(2):211-4. doi: 10.1097/00000658-192102000-00006.

No abstract available.

Cite
Ransohoff JL, Friedlander A. SOLID TUMORS OF THE MESENTERY. Ann Surg. 1921;73(2):211-4doi: 10.1097/00000658-192102000-00006.
Ransohoff, J. L., & Friedlander, A. (1921). SOLID TUMORS OF THE MESENTERY. Annals of surgery, 73(2), 211-4. https://doi.org/10.1097/00000658-192102000-00006
Ransohoff, J L, and Friedlander, A. "SOLID TUMORS OF THE MESENTERY." Annals of surgery vol. 73,2 (1921): 211-4. doi: https://doi.org/10.1097/00000658-192102000-00006
Ransohoff JL, Friedlander A. SOLID TUMORS OF THE MESENTERY. Ann Surg. 1921 Feb;73(2):211-4. doi: 10.1097/00000658-192102000-00006. PMID: 17864414; PMCID: PMC1410595.
Copy Download .nbib Format: NLM
II. The Treatment of Gangrenous Hernia.

Annals of surgery

Ransohoff J.
PMID: 17859832
Ann Surg. 1892 Oct;16(4):336-51. doi: 10.1097/00000658-189207000-00016.

No abstract available.

Cite
Ransohoff J. II. The Treatment of Gangrenous Hernia. Ann Surg. 1892;16(4):336-51doi: 10.1097/00000658-189207000-00016.
Ransohoff, J. (1892). II. The Treatment of Gangrenous Hernia. Annals of surgery, 16(4), 336-51. https://doi.org/10.1097/00000658-189207000-00016
Ransohoff, J. "II. The Treatment of Gangrenous Hernia." Annals of surgery vol. 16,4 (1892): 336-51. doi: https://doi.org/10.1097/00000658-189207000-00016
Ransohoff J. II. The Treatment of Gangrenous Hernia. Ann Surg. 1892 Oct;16(4):336-51. doi: 10.1097/00000658-189207000-00016. PMID: 17859832; PMCID: PMC1428774.
Copy Download .nbib Format: NLM
VIII. Acute Perforating Sigmoiditis in Children.

Annals of surgery

Ransohoff J.
PMID: 17863050
Ann Surg. 1913 Aug;58(2):218-25. doi: 10.1097/00000658-191308000-00008.

No abstract available.

Cite
Ransohoff J. VIII. Acute Perforating Sigmoiditis in Children. Ann Surg. 1913;58(2):218-25doi: 10.1097/00000658-191308000-00008.
Ransohoff, J. (1913). VIII. Acute Perforating Sigmoiditis in Children. Annals of surgery, 58(2), 218-25. https://doi.org/10.1097/00000658-191308000-00008
Ransohoff, J. "VIII. Acute Perforating Sigmoiditis in Children." Annals of surgery vol. 58,2 (1913): 218-25. doi: https://doi.org/10.1097/00000658-191308000-00008
Ransohoff J. VIII. Acute Perforating Sigmoiditis in Children. Ann Surg. 1913 Aug;58(2):218-25. doi: 10.1097/00000658-191308000-00008. PMID: 17863050; PMCID: PMC1407548.
Copy Download .nbib Format: NLM
WREDEN'S METHOD OF RECONSTRUCTING VOLUNTARY ANAL CONTROL.

Annals of surgery

Ransohoff JL.
PMID: 17866150
Ann Surg. 1929 Aug;90(2):317-8. doi: 10.1097/00000658-192908000-00014.

No abstract available.

Cite
Ransohoff JL. WREDEN'S METHOD OF RECONSTRUCTING VOLUNTARY ANAL CONTROL. Ann Surg. 1929;90(2):317-8doi: 10.1097/00000658-192908000-00014.
Ransohoff, J. L. (1929). WREDEN'S METHOD OF RECONSTRUCTING VOLUNTARY ANAL CONTROL. Annals of surgery, 90(2), 317-8. https://doi.org/10.1097/00000658-192908000-00014
Ransohoff, J L. "WREDEN'S METHOD OF RECONSTRUCTING VOLUNTARY ANAL CONTROL." Annals of surgery vol. 90,2 (1929): 317-8. doi: https://doi.org/10.1097/00000658-192908000-00014
Ransohoff JL. WREDEN'S METHOD OF RECONSTRUCTING VOLUNTARY ANAL CONTROL. Ann Surg. 1929 Aug;90(2):317-8. doi: 10.1097/00000658-192908000-00014. PMID: 17866150; PMCID: PMC1398873.
Copy Download .nbib Format: NLM
GRP78 autoantibodies initiate the breakdown of the blood-brain barrier in neuromyelitis optica.

Oncotarget

Shimizu F, Ransohoff RM.
PMID: 29290939
Oncotarget. 2017 Nov 21;8(63):106175-106176. doi: 10.18632/oncotarget.22589. eCollection 2017 Dec 05.

No abstract available.

Cite
Shimizu F, Ransohoff RM. GRP78 autoantibodies initiate the breakdown of the blood-brain barrier in neuromyelitis optica. Oncotarget. 2017;8(63):106175-106176doi: 10.18632/oncotarget.22589.
Shimizu, F., & Ransohoff, R. M. (2017). GRP78 autoantibodies initiate the breakdown of the blood-brain barrier in neuromyelitis optica. Oncotarget, 8(63), 106175-106176. https://doi.org/10.18632/oncotarget.22589
Shimizu, Fumitaka, and Ransohoff, Richard M. "GRP78 autoantibodies initiate the breakdown of the blood-brain barrier in neuromyelitis optica." Oncotarget vol. 8,63 (2017): 106175-106176. doi: https://doi.org/10.18632/oncotarget.22589
Shimizu F, Ransohoff RM. GRP78 autoantibodies initiate the breakdown of the blood-brain barrier in neuromyelitis optica. Oncotarget. 2017 Nov 21;8(63):106175-106176. doi: 10.18632/oncotarget.22589. eCollection 2017 Dec 05. PMID: 29290939; PMCID: PMC5739724.
Copy Download .nbib Format: NLM
Correction: Selective Chemokine Receptor Usage by Central Nervous System Myeloid Cells in CCR2-Red Fluorescent Protein Knock-In Mice.

PloS one

Saederup N, Cardona AE, Croft K, Mizutani M, Cotleur AC, Tsou CL, Ransohoff RM, Charo IF.
PMID: 28448577
PLoS One. 2017 Apr 27;12(4):e0176931. doi: 10.1371/journal.pone.0176931. eCollection 2017.

[This corrects the article DOI: 10.1371/journal.pone.0013693.].

Cite
Saederup N, Cardona AE, Croft K, et al. Correction: Selective Chemokine Receptor Usage by Central Nervous System Myeloid Cells in CCR2-Red Fluorescent Protein Knock-In Mice. PLoS One. 2017;12(4):e0176931doi: 10.1371/journal.pone.0176931.
Saederup, N., Cardona, A. E., Croft, K., Mizutani, M., Cotleur, A. C., Tsou, C. L., Ransohoff, R. M., & Charo, I. F. (2017). Correction: Selective Chemokine Receptor Usage by Central Nervous System Myeloid Cells in CCR2-Red Fluorescent Protein Knock-In Mice. PloS one, 12(4), e0176931. https://doi.org/10.1371/journal.pone.0176931
Saederup, Noah, et al. "Correction: Selective Chemokine Receptor Usage by Central Nervous System Myeloid Cells in CCR2-Red Fluorescent Protein Knock-In Mice." PloS one vol. 12,4 (2017): e0176931. doi: https://doi.org/10.1371/journal.pone.0176931
Saederup N, Cardona AE, Croft K, Mizutani M, Cotleur AC, Tsou CL, Ransohoff RM, Charo IF. Correction: Selective Chemokine Receptor Usage by Central Nervous System Myeloid Cells in CCR2-Red Fluorescent Protein Knock-In Mice. PLoS One. 2017 Apr 27;12(4):e0176931. doi: 10.1371/journal.pone.0176931. eCollection 2017. PMID: 28448577; PMCID: PMC5407805.
Copy Download .nbib Format: NLM
New BBB Model Reveals That IL-6 Blockade Suppressed the BBB Disorder, Preventing Onset of NMOSD.

Neurology(R) neuroimmunology & neuroinflammation

Takeshita Y, Fujikawa S, Serizawa K, Fujisawa M, Matsuo K, Nemoto J, Shimizu F, Sano Y, Tomizawa-Shinohara H, Miyake S, Ransohoff RM, Kanda T.
PMID: 34667128
Neurol Neuroimmunol Neuroinflamm. 2021 Oct 19;8(6). doi: 10.1212/NXI.0000000000001076. Print 2021 Nov.

BACKGROUND AND OBJECTIVES: To evaluate the pathophysiology of neuromyelitis optica spectrum disorder (NMOSD) and the therapeutic mechanism and levels of interleukin-6 (IL-6) blockade (satralizumab), especially with respect to blood-brain barrier (BBB) disruption with the new in vitro and ex...

Cite
Takeshita Y, Fujikawa S, Serizawa K, et al. New BBB Model Reveals That IL-6 Blockade Suppressed the BBB Disorder, Preventing Onset of NMOSD. Neurol Neuroimmunol Neuroinflamm. 2021;8(6)doi: 10.1212/NXI.0000000000001076.
Takeshita, Y., Fujikawa, S., Serizawa, K., Fujisawa, M., Matsuo, K., Nemoto, J., Shimizu, F., Sano, Y., Tomizawa-Shinohara, H., Miyake, S., Ransohoff, R. M., & Kanda, T. (2021). New BBB Model Reveals That IL-6 Blockade Suppressed the BBB Disorder, Preventing Onset of NMOSD. Neurology(R) neuroimmunology & neuroinflammation, 8(6), . https://doi.org/10.1212/NXI.0000000000001076
Takeshita, Yukio, et al. "New BBB Model Reveals That IL-6 Blockade Suppressed the BBB Disorder, Preventing Onset of NMOSD." Neurology(R) neuroimmunology & neuroinflammation vol. 8,6 (2021). doi: https://doi.org/10.1212/NXI.0000000000001076
Takeshita Y, Fujikawa S, Serizawa K, Fujisawa M, Matsuo K, Nemoto J, Shimizu F, Sano Y, Tomizawa-Shinohara H, Miyake S, Ransohoff RM, Kanda T. New BBB Model Reveals That IL-6 Blockade Suppressed the BBB Disorder, Preventing Onset of NMOSD. Neurol Neuroimmunol Neuroinflamm. 2021 Oct 19;8(6). doi: 10.1212/NXI.0000000000001076. Print 2021 Nov. PMID: 34667128; PMCID: PMC8529420.
Copy Download .nbib Format: NLM
Effects of neuromyelitis optica-IgG at the blood-brain barrier in vitro.

Neurology(R) neuroimmunology & neuroinflammation

Takeshita Y, Obermeier B, Cotleur AC, Spampinato SF, Shimizu F, Yamamoto E, Sano Y, Kryzer TJ, Lennon VA, Kanda T, Ransohoff RM.
PMID: 28018943
Neurol Neuroimmunol Neuroinflamm. 2016 Dec 19;4(1):e311. doi: 10.1212/NXI.0000000000000311. eCollection 2017 Jan.

OBJECTIVE: To address the hypothesis that physiologic interactions between astrocytes and endothelial cells (EC) at the blood-brain barrier (BBB) are afflicted by pathogenic inflammatory signaling when astrocytes are exposed to aquaporin-4 (AQP4) antibodies present in the immunoglobulin G (IgG)...

Cite
Takeshita Y, Obermeier B, Cotleur AC, et al. Effects of neuromyelitis optica-IgG at the blood-brain barrier in vitro. Neurol Neuroimmunol Neuroinflamm. 2016;4(1):e311doi: 10.1212/NXI.0000000000000311.
Takeshita, Y., Obermeier, B., Cotleur, A. C., Spampinato, S. F., Shimizu, F., Yamamoto, E., Sano, Y., Kryzer, T. J., Lennon, V. A., Kanda, T., & Ransohoff, R. M. (2017). Effects of neuromyelitis optica-IgG at the blood-brain barrier in vitro. Neurology(R) neuroimmunology & neuroinflammation, 4(1), e311. https://doi.org/10.1212/NXI.0000000000000311
Takeshita, Yukio, et al. "Effects of neuromyelitis optica-IgG at the blood-brain barrier in vitro." Neurology(R) neuroimmunology & neuroinflammation vol. 4,1 (2017): e311. doi: https://doi.org/10.1212/NXI.0000000000000311
Takeshita Y, Obermeier B, Cotleur AC, Spampinato SF, Shimizu F, Yamamoto E, Sano Y, Kryzer TJ, Lennon VA, Kanda T, Ransohoff RM. Effects of neuromyelitis optica-IgG at the blood-brain barrier in vitro. Neurol Neuroimmunol Neuroinflamm. 2016 Dec 19;4(1):e311. doi: 10.1212/NXI.0000000000000311. eCollection 2017 Jan. PMID: 28018943; PMCID: PMC5173350.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 83 entries